Soliton Inc
  • Clinicians
  • Patients
  • RAP
  • Trials
  • Standards
  • About
  • Investors
  • News
  • Sign-Up

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Scientific Advisory Board
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar

Soliton Announces Filing of Form S-1 Registering the Shares Issued in Private Placement at $14.00 per Unit

Jul 2, 2019

Soliton Partners with Capital Laser and Skin Care to Advance Pivotal Cellulite Trial

Jul 1, 2019

Soliton's Inclusion in the Russell 2000 and 3000 will be Effective After the Close of the Market Today

Jun 28, 2019

Soliton Engages CRO to begin Pivotal Cellulite Trial

Jun 25, 2019

Soliton to be Added to the Russell 2000 and 3000 Indexes on June 28, 2019

Jun 18, 2019

Soliton Announces $9.45 Million Private Placement

Jun 17, 2019

Soliton Announces Long-Term Cellulite Trial Results to be Presented at The Aesthetics Show on July 11-14, 2019

Jun 12, 2019

Soliton Confirms Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance for Today at 4:30 PM ET

Jun 11, 2019

Soliton Announces Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance

Jun 5, 2019

Soliton Announces Significant Discovery of Acoustic Subcision for Treatment of Cellulite

Jun 4, 2019
RSS
    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12

    To Follow Our Progress, Sign Up Here:

    Additional Information

    • Privacy Policy
    • Contact

    Social Media

    Links

    • About
    • Clinicians
    • Patients
    • Technology
    • Trials
    • Standards

    © 2021 Soliton Inc. All Rights Reserved, Soliton Inc.

      • Clinicians
      • Patients
      • RAP
      • Trials
      • Standards
      • Our Future
      • About
      • Investors